{"protocolSection":{"identificationModule":{"nctId":"NCT03379857","orgStudyIdInfo":{"id":"6640"},"organization":{"fullName":"University Hospital, Strasbourg, France","class":"OTHER"},"briefTitle":"Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke","officialTitle":"Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke","acronym":"CANNASTROKE"},"statusModule":{"statusVerifiedDate":"2019-06","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2018-01-11","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-01-11","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-01-11","type":"ESTIMATED"},"studyFirstSubmitDate":"2017-09-29","studyFirstSubmitQcDate":"2017-12-19","studyFirstPostDateStruct":{"date":"2017-12-20","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-06-11","lastUpdatePostDateStruct":{"date":"2019-06-13","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"University Hospital, Strasbourg, France","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Incidence of strokes has increased these last 20 years in young population. This rise could be linked to alcohol, tobacco or drug use like cannabis. Cannabis has previously been descripted as a potential factor of reversible vasoconstriction. The main objective is to show that an exhaustive assessment of a stroke facing a young person frequently lead to a diagnostic of reversible vasoconstriction due to cannabis use. Evaluation will focus on prevalence of strokes secondary to a reversible vasoconstriction attributable to cannabis in young subjects.\n\nThere's a real public healthcare interest in terms of primary and secondary prevention to evaluate the role of cannabis as a risk factor of stroke in young population."},"conditionsModule":{"conditions":["Stroke","Cannabis Use"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","interventionModelDescription":"Cannabis User","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":300,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Cannabis User","type":"OTHER","interventionNames":["Other: Drug urinal test"]}],"interventions":[{"type":"OTHER","name":"Drug urinal test","description":"Non Applicable","armGroupLabels":["Cannabis User"],"otherNames":["Magnetic Resonance Imaging","Computerized Tomography Scan","Transcranial Doppler Ultrasound"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Evaluation Cannabis use","timeFrame":"12 months"},{"measure":"Reversible vasoconstriction on medical imaging of intracranial arteries at different moment","description":"medical imaging of intracranial arteries will show new stenoses (topography, number, evolution), and new ischemic or cerebral haemorrhagic lesions","timeFrame":"12 months."}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subject between 18 and 45 years old\n* Stroke confirmed by medical imaging\n* Written informed consent (subject, nearby or emergency procedure)\n* Subject affiliate to a local healthcare insurance office\n* For female of childbearing potential, an adequate contraceptive measur\n\nExclusion Criteria:\n\n* Subject with psychiatric disorder, unable to understand the study or cooperate\n* Subject under guardianship or forfeiture of liberty\n* Pregnant or breastfeeding woman\n* Subject in period of exclusion due to another study or still in follow-up of an interventional study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"45 Years","stdAges":["ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Valérie WOLFF, MD","role":"CONTACT","phone":"+33 3 88 12 86 06","email":"valerie.wolff@chru-strasbourg.fr"}],"overallOfficials":[{"name":"Valérie WOLFF, MD","affiliation":"Hôpitaux Universitaires de Strasbourg","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Chu Jean Minjoz","status":"RECRUITING","city":"Besancon","zip":"25030","country":"France","contacts":[{"name":"Thierry MOULIN","role":"CONTACT","phone":"+33 3 81 66 84 38","email":"thierry.moulin@univ-fcomte.fr"},{"name":"Thierry MOULIN","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":47.24878,"lon":6.01815}},{"facility":"Unite Neuro-Vasculaire","status":"RECRUITING","city":"Colmar","zip":"68024","country":"France","contacts":[{"name":"Francis VUILLEMET","role":"CONTACT","phone":"+33 3 89 12 41 50","email":"francis.vuillemet@ch-colmar.fr"},{"name":"Francis VUILLEMET","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":48.08333,"lon":7.36667}},{"facility":"Chu Bocage","status":"RECRUITING","city":"Dijon","zip":"21079","country":"France","contacts":[{"name":"Yannick BEJOT","role":"CONTACT","phone":"+33 3 80 29 37 53","email":"yannick.bejot@chu-dijon.fr"},{"name":"Yannick BEJOT","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":47.31667,"lon":5.01667}},{"facility":"C.H. G. Muller","status":"RECRUITING","city":"Mulhouse","zip":"68070","country":"France","contacts":[{"name":"Eric SCHLUCK","role":"CONTACT","phone":"+33 3 89 64 61 81","email":"schlucke@ch-mulhouse.fr"},{"name":"Eric SCHLUCK","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":47.75,"lon":7.33333}},{"facility":"Hopital Central","status":"RECRUITING","city":"Nancy","zip":"54035","country":"France","contacts":[{"name":"Sébastien RICHARD","role":"CONTACT","phone":"+33 3 83 85 22 56","email":"s.richard@chru-nancy.fr"},{"name":"Sébastien RICHARD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":48.68439,"lon":6.18496}},{"facility":"Les Hôpitaux Universitaires de Strasbourg","status":"RECRUITING","city":"Strasbourg","zip":"67098","country":"France","contacts":[{"name":"Valérie WOLFF, MD","role":"CONTACT","phone":"33 3 88 12 86 06","email":"valerie.wolff@chru-strasbourg.fr"},{"name":"Valérie WOLFF, M","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Valérie LAUER","role":"SUB_INVESTIGATOR"},{"name":"Simona SABAU PHILIPPI","role":"SUB_INVESTIGATOR"},{"name":"Mihaela DIACONU","role":"SUB_INVESTIGATOR"},{"name":"Danièla BINDILA","role":"SUB_INVESTIGATOR"},{"name":"Lelyzaveta ZINCHENKO","role":"SUB_INVESTIGATOR"},{"name":"Véronique QUENARDELLE","role":"SUB_INVESTIGATOR"},{"name":"Stéphane KREMER","role":"SUB_INVESTIGATOR"}],"geoPoint":{"lat":48.58392,"lon":7.74553}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002189","term":"Marijuana Abuse"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000019966","term":"Substance-Related Disorders"},{"id":"D000064419","term":"Chemically-Induced Disorders"},{"id":"D000001523","term":"Mental Disorders"}],"browseLeaves":[{"id":"M5139","name":"Marijuana Abuse","asFound":"Cannabis","relevance":"HIGH"},{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M11997","name":"Neoplasm Metastasis","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21527","name":"Substance-Related Disorders","relevance":"LOW"},{"id":"M29992","name":"Chemically-Induced Disorders","relevance":"LOW"},{"id":"M4505","name":"Mental Disorders","relevance":"LOW"},{"id":"M14163","name":"Psychotic Disorders","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC25","name":"Substance Related Disorders"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"BC04","name":"Neoplasms"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}